Primary record
(R,R)-Formoterol tartrate; N-(2-Hydroxy-5-((1R)-1-hydroxy-2-(((1R)-2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)formamide (2R,3R)-2,3-dihydroxybutanedioate (1:1)
- 库存
- 1,226 克
- 纯度
- 99.1 %
- CAS
- 200815-49-2
化合物标识与属性
- CAS
- 200815-49-2
- PubChem CID
- 9827062
- SMILES
- C[C@H](CC1=CC=C(C=C1)OC)NC[C@@H](C2=CC(=C(C=C2)O)NC=O)O.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
- Canonical SMILES
- COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1.O=C(O)[C@H](O)[C@@H](O)C(=O)O
名称与同义词
- Arformoterol tartrate
- Brovana
- 200815-49-2
- Formoterol tartrate
- Arformoteroltartrate
- Brovana (TN)
- Arformotero ltartrate
- (R,R)-Arformoterol tartrate
- Brovana Inhalation Solution
- (R,R)-Formoterol tartrate
- RefChem:56496
- Arformoterol Tartrate [USAN]
- UNII-5P8VJ2I235
- (R,R)-Eformoterol tartrate
- 5P8VJ2I235
- Arformoterol tartrate (USAN)
- DTXSID80173903
- Formoterol r,r-form l-tartrate
- MSK1330A
- orb1306052
- orb3025907
- Arformoterol Tartrate Inhalation
- DTXCID6096394
- SCHEMBL31470606
- C23H30N2O10
- FCSXYHUNDAXDRH-OKMNHOJOSA-N
- GLXC-07346
- 67346-49-0(Free Base)
- MSK1330A-100M
- (R,R)-Formoterol Impurity Tartrate
- C19H24N2O4.C4H6O6
- ARFORMOTEROL TARTRATE [VANDF]
- MFCD07785830
- s5217
- ARFORMOTEROL TARTRATE (MART.)
- ARFORMOTEROL TARTRATE [MART.]
- AKOS005145740
- ARFORMOTEROL TARTRATE [WHO-DD]
- CB10250
- CCG-269651
- CID9827062
- CS-O-00839
- EBC-126022
- Arformoterol tartrate, >=98% (HPLC)
- Arformoterol Tartrate Inhalation Solution
- AN-13010
- Arformoterol tartrate - Bio-X trade mark
- BA171831
- BA300007
- BS-42158
- Formamide, N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-, (2R,3R)-2,3-dihydroxybutanedioate (1:1)
- ARFORMOTEROL TARTRATE [ORANGE BOOK]
- C19-H24-N2-O4.C4-H6-O6
- FORMOTEROL R,R-FORM L-TARTRATE [MI]
- FT-0697952
- Z6130
- A12795
- D02981
- 815F492
- A939045
- Arformoterol tartrate Solution in Methanol, 100ug/mL
- Q27262686
- (-)-N-(2-Hydroxy-5-((1R)-1-hydroxy-2-(((1R)-2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)formamide hydrogen (2R,3R)-2,3-dihydroxybutanedioate (salt)
- (2R,3R)-2,3-dihydroxybutanedioic acid;N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide
- Formamide, N-(2-hydroxy-5-((1R)-1-hydroxy-2-(((1R)-2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt)
- N-[2-Hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-formamide (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt)
- (2R,3R)-2,3-Dihydroxybutanedioic acid--N-{2-hydroxy-5-[(1R)-1-hydroxy-2-{[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino}ethyl]phenyl}formamide (1/1)
- (2R,3R)-2,3-dihydroxybutanedioic acid; N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methyl-ethyl]amino]ethyl]phenyl]formamide
- (2R,3R)-2,3-dihydroxybutanedioic acid;N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methyl-ethyl]amino]ethyl]phenyl]formamide
- (R,R)-Formoterol tartrate; N-(2-Hydroxy-5-((1R)-1-hydroxy-2-(((1R)-2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)formamide (2R,3R)-2,3-dihydroxybutanedioate (1:1)
- [(2R)-2-(3-formamido-4-hydroxyphenyl)-2-hydroxyethyl]-[(2R)-1-(4-methoxyphenyl)propan-2-yl]azanium;(2R,3R)-2,3,4-trihydroxy-4-oxobutanoate
- Formamide, N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt)
- N-(2-Hydroxy-5-((1R)-1-hydroxy-2-(((1R)-2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)formamide (2R,3R)-2,3-dihydroxybutanedioate (1:1)
- N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide (2R,3R)-2,3-dihydroxybutane dioate
- N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide (2R,3R)-2,3-dihydroxybutanedioate
- N-[2-Hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide L-tartrate